Mind Medicine Net Income
| MNMDDelisted Stock | USD 15.38 0.27 1.79% |
As of the 11th of February 2026, Mind Medicine secures the Mean Deviation of 3.07, downside deviation of 3.84, and Risk Adjusted Performance of 0.09. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mind Medicine, as well as the relationship between them. Please verify Mind Medicine treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Mind Medicine is priced some-what accurately, providing market reflects its recent price of 15.38 per share. Given that Mind Medicine has jensen alpha of 0.3681, we recommend you to check Mind Medicine's last-minute market performance to make sure the company can sustain itself at a future point.
Mind Medicine's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Mind Medicine's valuation are provided below:Mind Medicine does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Mind |
Search Suggestions
| MN | Manning Napier | CompanyDelisted |
| MNSBP | MainStreet Bancshares | Company |
| MNR | Mach Natural Resources | Company |
| MNBCX | Pioneer Amt Free Municipal | Mutual Fund |
| MNA | IQ Merger Arbitrage | ETF |
| MNW | MNW | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Mind Medicine reported net income of (108.68 Million). This is 131.84% lower than that of the Biotechnology sector and 255.15% lower than that of the Health Care industry. The net income for all United States stocks is 119.03% higher than that of the company.
Mind Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mind Medicine's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mind Medicine could also be used in its relative valuation, which is a method of valuing Mind Medicine by comparing valuation metrics of similar companies.Mind Medicine is currently under evaluation in net income category among its peers.
Mind Fundamentals
| Return On Equity | -0.86 | |||
| Return On Asset | -0.34 | |||
| Current Valuation | 1.3 B | |||
| Shares Outstanding | 97.22 M | |||
| Shares Owned By Insiders | 0.59 % | |||
| Shares Owned By Institutions | 41.64 % | |||
| Number Of Shares Shorted | 15.05 M | |||
| Price To Book | 11.22 X | |||
| EBITDA | (105.87 M) | |||
| Net Income | (108.68 M) | |||
| Cash And Equivalents | 105.74 M | |||
| Cash Per Share | 3.71 X | |||
| Total Debt | 21.85 M | |||
| Current Ratio | 13.86 X | |||
| Book Value Per Share | 1.70 X | |||
| Cash Flow From Operations | (79.13 M) | |||
| Short Ratio | 7.82 X | |||
| Earnings Per Share | (1.98) X | |||
| Target Price | 28.67 | |||
| Number Of Employees | 74 | |||
| Beta | 2.62 | |||
| Market Capitalization | 1.45 B | |||
| Total Asset | 302.15 M | |||
| Retained Earnings | (398.88 M) | |||
| Working Capital | 242.77 M | |||
| Net Asset | 302.15 M |
About Mind Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mind Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mind Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mind Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Mind Stock
If you are still planning to invest in Mind Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mind Medicine's history and understand the potential risks before investing.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |